Physical activity modulates effects of some genetic polymorphisms affecting cardiovascular risk in men aged over 40 years

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 13, Issue 4, 2003, Pages 202-210

  Pisciotta, L ^a   Cantafora, A ^b   Piana, A ^a   Masturzo, P ^a   Cerone, R ^c   Minniti, G ^c   Bellocchio, A ^a   Reggiani, E ^d   Armani, U ^a   Bertolini, S ^a,e  

^a UNIVERSITY OF GENOA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e NONE   (Italy)

Author keywords

Genetic polymorphisms (Apo E, FABP 2, Apo AII, HL and MTHFR); Lipoprotein pattern; Physical fitness; Plasma homocysteine

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN A2; APOLIPOPROTEIN E; FATTY ACID BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPID; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN; CHOLESTEROL; PRIMER DNA; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CONTROLLED STUDY; CYCLING; DIETARY INTAKE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PHYSICAL ACTIVITY; RISK ASSESSMENT; SITTING; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; GENETICS; GLUCOSE BLOOD LEVEL; MEDICAL RECORD; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; POLYMERASE CHAIN REACTION;

ADULT; APOLIPOPROTEINS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET RECORDS; DNA PRIMERS; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 1542494194     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-4753(03)80012-1     Document Type: Article

References (50)

1. Bijnen FCH, Caspersen CJ, Feskens EJM, Saris WHM, Mosterd WL, Kromhout D (1998) Physical activity and 10-year mortality for cardiovascular diseases and all causes. The Zutphen Elderly Study. Arch Intern Med 158: 1499-1505
2. Paffenbarger RS, Lee I-M (1996) Physical activity and fitness for health and longevity. RQES 67 (Suppl.): 11-28
3. Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Rodahl K (1993) Physical fitness as a predictor of mortality among healthy, middle aged Norwegian men. New Engl J Med 328: 533-537
4. Shephard RJ, Balady GJ (1999) Exercise as cardiovascular therapy. Circulation 99: 963-972
5. Despres JP, Lamarche B (1994) Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease. J Int Med 236: 7-22
6. Foger B, Wohlfarter T, Ritsch A, Lechleitner M, Miller CH, Dienstl A, Patsch JR (1994) Kinetics of lipids, apolipoproteins, and cholesteryl ester transfer protein in plasma after a bicycle marathon. Metabolism 43: 633-639
7. Halle M, Berg A, Konig D, Keul J, Baumstark MW (1997) Differences in the concentration and composition of low-density lipoprotein subfraction particles between sedentary and trained hypercholesterolemic men. Metabolism 46: 186-191
8. Marrugat J, Elosua R, Covas MI, Molina L, Rubies-Prat J (1996) Amount and intensity of physical activity, physical fitness, and serum lipids in men. Am J Epidemiol 143: 562-569
9. Williams PT (1997) Relationship of distance run per week to coronary heart disease risk factors in 8283 male runners. The National Runners' Health Study. Arch Intern Med 157: 191-198
10. Williams PT, Krauss RM, Vranizan KM, Woods PDS (1990) Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. Circulation 8: 1293-1304
11. Weintraub MS, Rosen Y, Otto R, Eisenberg S, Breslow JL (1989) Physical exercise conditioning in the absence of weight loss reduces fasting and postprandial triglyceride-rich lipoprotein levels. Circulation 79: 1007-1014
12. Houmard JA, Bruno NJ, Bruner RK, McCammon MR, Israel RG, Barakat HA (1994) Effects of exercise training on the chemical composition of plasma LDL. Arterioscler Thromb 14: 325-330
13. Festa A, D'Agostino R, Mykkanen L, Tracy R, Howard BV, Haffner SM (1999) Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. Arterioscler Thromb Vasc Biol 19: 605-610
14. Gardner CD, Fortmann SP, Krauss RM (1996) Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276: 875-881
15. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR, Slentz CA (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347: 1483-1492
16. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, Uterman G (1991) The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49: 338-349
17. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ (1994) Apolipoprotein E allele, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 272: 1666-1671
18. Dart A, Sherrard B, Simpson H (1997) Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease. Atherosclerosis 130: 161-170
19. Taimela S, Lehtimaki T, Porkka KVK, Rasanen L, Viikari JSA (1996) The effect of physical activity on serum total and low-density lipoprotein cholesterol concentrations varies with apolipoprotein E phenotype in male children and young adults: The Cardiovascular Risk in Young Finns Study. Metabolism 45: 797-803
20. St-Amand J, Prud'homme D, Moorjani S, Nadeau A, Tremblay A, Bouchard C, Lupien PJ, Depres JP (1999) Apolipoprotein E polymorphism and the relationships of physical fitness to plasma lipoprotein-lipid levels in men and women. Med Sci Sports Exerc 3: 692-697
21. Van't Hooft FM, Ruotolo G, Boquist S, de Faire U, Eggertsen G, Hamsten A (2001) Human evidence that apolipoprotein A-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 104: 1223-1228
22. Baier LJ, Pacchettini JC, Knowler WC, Eads J, Prolisso G, Tataranni PA, Mochizuki H, Bennett PH, Bogardus C, Prochazka M (1995) An amino acid substitution in the human Intestinal Fatty Acid Binding Protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95: 1281-1287
23. Guerra R, Wang J, Grundy SM, Cohen JC (1997) A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 94: 4532-4537
24. Tahvanainen E, Syvänne M, Frick MH, Murtomäki-Repo S, Antikainen M, Kesäniemi A, Kauma H, Pasternak A, Taskinen M-R, Ehnholm C (1998) Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. J Clin Invest 101: 956-960
25. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM (1998) Homocysteine and ischemic heart disease. Arch Intern Med 158: 862-867
26. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB (2002) Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 31: 59-70
27. Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, Block PC, Holzgang CR, Anderson PH, Seltzer D, Upson B, Lin QR (1997) The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 17: 1157-1162
28. Gemmati D, Previati M, Serino ML, Moratelli S, Guerra S, Capitani S, Forini E, Ballerini G, Scapoli GL (1999) Low folate levels and thermolabile methylene-tetrahydrofolate reductase as primary determinant of mild hyper-homocysteinemia in normal and thromboembolic subjects. Arterioscler Thromb Vasc Biol 19: 1761-1767
29. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland PM, Kvale G (1995) Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274: 1526-1533
30. Mennen LI, Portier de Courcy G, Guilland J-C, Ducros V, Bertrais S, Nicolas J-P, Maurel M, Zarebska M, Favier A, Franchisseur C, Hercberg S, Galan P (2002) Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr 76: 1279-1289
31. Bernstein M, Sloutskis D, Kumanyka S, Sparti A, Schutz Y, Morabia A (1998) Data-based approach for developing a physical activity frequency questionnaire. Am J Epidemiol 147: 147-154
32. Schroder H, Covas MI, Marrugat J, Vila J, Pena A, Alcantara M, Masia R (2001) Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin Nutr 20: 429-437
33. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM (1993) Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 39: 263-271
34. Gambert P, Bouzerand-Gambert C, Athias A, Farnier M, Lallemant C (1990) Human low density lipoprotein subfractions separated by gradient gel electrophoresis: composition, distribution and alterations induced by cholesteryl ester tranfer protein. J Lipid Res 31: 1199-1210
35. Eisenberg S, Gavish D, Oschry Y, Fainaru M, Decklelbaum RJ (1984) Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. J Clin Invest 74: 470-482
36. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press; Cold Spring Harbor, NY
37. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548
38. Frosst P, Blom HJ, Milas R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 10: 111-113
39. rd ed. Freeman and Co., San Francisco, CA
40. Barrett JA (2002) Quantitative trait loci: methods and protocols. Camp NJ and Cox E (eds). Humana Press, Totowa, New Jersey
41. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM (1996) Apolipoprotein E alleles and risk of coronary disease. A metaanalysis. Arterioscler Thromb Vasc Biol 16: 1250-1255
42. Margaglione M, Seripa D, Gravina C, Grandone E, Vecchione G, Cappucci G, Merla G, Papa S, Postiglione A, Di Minno G, Fazio VM (1998) Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke. Stroke 29: 399-403
43. Hagberg JM, Wilund KR, Ferrell RE (2000) APO E gene and gene-environment effects on plasma lipoprotein-lipid levels. Physiol Genomics 4: 101-108
44. Bernstein MS, Costanza MC, James RW, Morris MA, Cambien F, Raoux S, Morabia A (2002) Physical activity may modulate effects of ApoE genotype on lipid profile. Arterioscler Thromb Vasc Biol 22: 133-140
45. Seip RL, Moulin P, Cocke T, Tall A, Kohrt WM, Mankowitz K, Semenkovich CF, Ostlund R, Schonfeld G (1993) Exercise training decreases plasma cholesteryl ester transfer protein. Arterioscler Thromb 13: 1359-1367
46. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD (2003) Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 14: 179-189
47. Lamarche B, Tchernof A, Mauriege P, Cantin B, Dagenais GR, Lupien PJ, Despres J-P (1998) Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279: 1955-1961
48. Nigon F, Lesnik P, Rouis M, Chapman MJ (1991) Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 11: 298-306
49. Ali A, Mehra MR, Lavie CJ, Malik FS, Murgo JP, Lohmann TP, Li S, Lin H-C, Milani RV (1998) Modulatory impact of cardiac rehabilitation on hyperhomo-cysteinemia in patients with coronary artery disease and "normal" lipid levels. Am J Cardiol 82: 1543-1545
50. Giltay EJ, Hoogeveen EK, Elbers JMH, Gooren LJG, Asscheman H, Stehouwer CDA (1998) Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 139: 197-198